AlloVir
0 followers
‌
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Industries
Headquarters
Employees
Links
Org chart
Diana M. Brainard
Collapse
Vikas Sinha
President and Chief Financial Officer
Ann Leen
Chief Scientific Officer
Edward Miller
General Counsel
Alicia Defrancesco
Senior Director, Head Of Commercial Strategy And Operations
Sivaji Gundala
Head Of Quality Control
Julia Camara
Senior Manager, Quality Systems, Documentation & Training
